BCC's 2019 landmark paper on ROI in Pharma investigates the recent past performance of investments in pharmaceutical research and development, and discusses ways that companies are currently trying to improve ROI over the next decade. Join us for a walk through the highlights and a lively discussion with stakeholders.
Presenter: Valerie Kellogg, BCC Research Analyst
Date: TBD
Time: TBD
Where: WebEx
Cost: Free
Register HereOne of the most significant announcements out of ASCO 2019 (from Iovance Biotherapeutics Inc.) were two first-in-man studies of adoptive T cell therapy (ACT) in patients with melanoma and cervical cancer which had failed to respond to other treatments. The studies showed significant responses in both cancers. Of the several modalities of ACT, tumor-infiltrating leukocytes (TILs) have been studied the most to date. Join us for this discussion of a promising new treatment that just might show the way.
Presenter: Dr. Cheryl Lee Barton, BCC Research Analyst
Date: TBD
Time: TBD
Where: WebEx
Cost: Free
Register HereAnalyst Robert Eckard will examine the global market of resilient building design and planning. Join him for a brief overview of his research, the analyst’s take on the technological and economic trends that are affecting the market, coverage of drivers and regional dynamics and a live Q&A session.
Presenter: Robert Eckard, BCC Research Analyst
Date: TBD
Time: TBD
Where: WebEx
Cost: Free
Notify Me When Scheduled
